INSTIL BIO INC (TIL)
US45783C2008 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 140K | 34.845K -100.00% | 336.663K | 2.525M | 2.592M 2.65% | -100.00% | 10.1M | 10.1M | 10.1M | 10.1M | 10.1M | |||
| EBITDA YoY % growth | -6.57M | -33.38M -408.07% | -126.249M -357.79% | -192.941M -29.11% | -90.691M 58.24% | -64.939M 21.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.59M | -33.64M -410.47% | -146.713M -362.43% | -218.288M -30.68% | -166.144M 57.13% | -82.947M 4.83% | -106.814M -28.77% | -10.302M 90.36% | -404K 96.08% | -606K -50.00% | -808K -33.33% | -1.01M -25.00% | -1.313M -30.00% | |
| Operating Margin | N/A | -24,028.57% | -421,044.20% | -64,838.65% | N/A | -3,285.04% | -4,120.89% | N/A | -4.00% | -6.00% | -8.00% | -10.00% | -13.00% | |
| EPS YoY % growth | N/A | N/A | -27.42 | -33.46 -261.54% | -25.10 -292.64% | -12.62 47.40% | -15.34 -21.53% | -0.70 95.46% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.04 -52.94% | -3.41 8.90% | -3.84 -67.75% | -3.98 -12.41% | -4.15 -36.39% |
| Revenue Q2Q % growth | 1.279M | 639.663K | 639.663K | 639.663K | 639.663K -49.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.609M -60.32% | -23.53M -19.56% | -26.493M -94.42% | -27.554M -144.51% | -29.237M -41.87% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -3.54 65.96% | -2.13 | -1.41 | -66.31% |
| Q2 2024 Q2Q % growth | -2.29 18.21% | -3.01 | 0.72 | 23.92% |
| Q1 2024 Q2Q % growth | -3.74 57.50% | -2.25 | -1.49 | -66.05% |
| Q4 2023 Q2Q % growth | -1.99 58.54% | -2.87 | 0.88 | 30.75% |
| Q3 2023 Q2Q % growth | -10.40 -2,318.60% | -2.02 | -8.38 | -414.85% |
| Q2 2023 Q2Q % growth | -2.80 -508.70% | -3.30 | 0.50 | 15.13% |
| Q1 2023 Q2Q % growth | -8.80 -1,995.24% | -3.13 | -5.67 | -181.06% |
| Q4 2022 Q2Q % growth | -4.80 -1,016.28% | -8.35 | 3.55 | 42.51% |
| Q3 2022 Q2Q % growth | -0.43 -30.30% | -0.44 | 0.01 | 2.35% |
| Q2 2022 Q2Q % growth | -0.46 -70.37% | -0.42 | -0.04 | -10.55% |
| Q1 2022 Q2Q % growth | -0.42 36.36% | -0.39 | -0.03 | -8.48% |
| Q4 2021 Q2Q % growth | -0.43 | -0.37 | -0.06 | -17.45% |
| Q3 2021 Q2Q % growth | -0.33 | -0.33 | 0.00 | -0.84% |
| Q2 2021 Q2Q % growth | -0.27 | -0.21 | -0.06 | -30.40% |
| Q1 2021 Q2Q % growth | -0.66 | -0.52 | -0.14 | -26.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 959.5K | -959.5K | -100.00% | |
| Q4 2022 Q2Q % growth | 505K | -505K | -100.00% | |
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.78% | -9.78% | -24.19% | -24.64% |
| Revenue | N/A | N/A | 33.32% | N/A |